4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001708599-25-000095
Chief Scientific Officer sold 5,500 shares at $5.25 ($28,875)
- Chief Scientific Officer acquired 5,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-08-12 | Option exercise 10b5-1 | +5,500 | $0.06 | $330 | 5,500 | D: show line 1 in the form |
| Moreadith Randall Chief Scientific Officer | 2025-08-12 | Sale 10b5-1 | −5,500 | $5.25 | $28,875 | 0 | D: show line 2 in the form |
| Open-market sales · 5,500 sh · avg $5.25 · $28,875 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-08-12 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,500 | 473,490 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1755203256.xml…